色谱 ›› 2022, Vol. 40 ›› Issue (2): 165-174.DOI: 10.3724/SP.J.1123.2021.03025
周永顺, 龚剑*(), 杨可欣, 林粲源, 吴翠琴, 张舒寒
收稿日期:
2021-03-18
出版日期:
2022-02-08
发布日期:
2021-10-22
通讯作者:
龚剑
基金资助:
ZHOU Yongshun, GONG Jian*(), YANG Kexin, LIN Canyuan, WU Cuiqin, ZHANG Shuhan
Received:
2021-03-18
Online:
2022-02-08
Published:
2021-10-22
Contact:
GONG Jian
Supported by:
摘要:
沉积物中皮质类固醇激素(CSs)的痕量分析对探究其在环境多介质中的赋存状况和环境行为具有重要意义。然而目前相关研究主要集中在水样中糖皮质激素的测定,对基质更为复杂的环境固体样品中CSs的定量分析研究仍十分有限亦缺乏针对性、系统性,且目标物未能覆盖大多数常见常用的糖/盐CSs。本研究系统地优化了样品前处理过程和仪器分析中影响24种CSs测定准确性和灵敏度的条件,建立了采用超声波提取联合固相萃取技术对样品进行前处理,利用超高效液相色谱-串联质谱(UPLC-MS/MS)同时测定沉积物中24种CSs的分析方法。沉积物经冷冻干燥、研磨后,取2.0 g样品采用甲醇-丙酮(1∶1, v/v)超声提取,HLB固相萃取柱富集、净化,LC-NH2小柱二次净化,甲醇定容。目标物经Agilent ZORBAX Eclipse Plus C8反相色谱柱(100 mm×2.1 mm, 1.8 μm)分离,柱温30 ℃,进样量5 μL,以乙腈和0.1%(v/v)乙酸水溶液作为流动相进行梯度洗脱,流速0.3 mL/min。在电喷雾正离子模式(ESI+)下采用动态多反应(DMRM)选择离子监测(SIM)方式测定24种目标化合物,内标法定量。结果表明,24种CSs的方法检出限(LOD, S/N≥3)和定量限(LOQ, S/N≥10)分别为0.14~1.25 μg/kg和0.26~2.26 μg/kg,工作曲线在1.0~100 μg/L范围内具有良好的线性关系(R2>0.995)。在5、20、50 μg/kg的基质加标水平下,24种CSs的平均回收率为64.9%~125.1%,相对标准偏差为0.4%~12.6%(n=5)。应用该方法测定了3份珠江三角洲河流沉积物,其中有11种目标物被检出,含量范围为1.25~29.38 μg/kg。该方法净化效率高,灵敏可靠,适用于环境沉积物中多种天然和合成CSs的痕量检测。
中图分类号:
周永顺, 龚剑, 杨可欣, 林粲源, 吴翠琴, 张舒寒. 超声波提取-固相萃取-液相色谱-串联质谱法同时测定沉积物中24种皮质类固醇激素[J]. 色谱, 2022, 40(2): 165-174.
ZHOU Yongshun, GONG Jian, YANG Kexin, LIN Canyuan, WU Cuiqin, ZHANG Shuhan. Simultaneous determination of 24 corticosteroids in sediments based on ultrasonic extraction, solid-phase extraction, liquid chromatography, and tandem mass spectrometry[J]. Chinese Journal of Chromatography, 2022, 40(2): 165-174.
No. | Compound | Retention time/min | Monitoring ion pair (m/z) | Fragmentor/V | Collision energy/eV |
---|---|---|---|---|---|
1 | triamcinolone | 2.61 | 395.2/375.1* | 140 | 4 |
(曲安西龙) | 395.2/225.1 | 12 | |||
2 | aldosterone | 4.51 | 361.0/315.0 | 70 | 8 |
(醛固酮) | 361.0/343.0* | 4 | |||
3 | prednisolone | 5.73 | 361.2/343.2* | 70 | 4 |
(泼尼松龙) | 361.2/147.1 | 24 | |||
4 | cortisol | 6.11 | 363.2/327.2 | 95 | 12 |
(皮质醇) | 363.2/121.0* | 120 | 27 | ||
5 | prednisone | 6.19 | 359.2/171.0 | 95 | 36 |
(泼尼松) | 359.2/147.0* | 32 | |||
6 | cortisone | 6.76 | 361.2/163.1* | 150 | 12 |
(可的松) | 361.2/121.0 | 4 | |||
7 | methylprednisolone | 10.23 | 375.2/357.1* | 110 | 6 |
(甲基泼尼松龙) | 375.2/161.1 | 20 | |||
8 | betamethasone | 11.13 | 393.2/373.2* | 75 | 0 |
(倍他米松) | 393.2/355.2 | 8 | |||
9 | dexamethasone | 11.25 | 393.2/373.2* | 75 | 0 |
(地塞米松) | 393.2/355.2 | 8 | |||
10 | flumethasone | 11.59 | 411.2/253.1* | 70 | 12 |
(氟米松) | 411.2/121.0 | 40 | |||
11 | corticosterone | 11.63 | 347.0/121.0* | 20 | 25 |
(皮质酮) | 347.0/329.0 | 25 | |||
12 | beclomethasone | 11.86 | 409.2/391.1* | 110 | 6 |
(倍氯米松) | 409.2/146.9 | 30 | |||
13 | flunisolide | 12.40 | 495.2/121.0* | 90 | 16 |
(氟尼缩松) | 495.2/319.1 | 44 | |||
14 | triamcinolone acetonide | 12.52 | 435.2/415.2* | 75 | 4 |
(曲安奈德) | 435.2/397.2 | 12 | |||
15 | fluocinolone acetonide | 13.34 | 453.2/413.3* | 90 | 8 |
(醋酸氟轻松) | 453.2/337.2 | 8 | |||
16 | fluorometholone | 13.71 | 377.2/121.0* | 80 | 36 |
(氟米龙) | 377.2/173.1 | 24 | |||
17 | fludrocortisone acetate | 13.84 | 423.2/238.9* | 150 | 22 |
(醋酸氟氢可的松) | 432.2/120.9 | 36 | |||
18 | deflazacort | 14.04 | 442.2/123.9* | 170 | 50 |
(地夫可特) | 442.2/141.9 | 36 | |||
19 | budesonide | 15.43 | 431.2/147.0* | 90 | 36 |
(布地奈德) | 431.1/173.1 | 28 | |||
20 | deoxycorticosterone acetate | 17.20 | 373.24/97.1* | 110 | 28 |
(醋酸脱氧皮质酮) | 373.2/108.9 | 20 | |||
21 | amcinonide | 17.36 | 503.2/339.1* | 75 | 12 |
(安西奈德) | 503.2/399.2 | 8 | |||
22 | clobetasol propionate | 17.61 | 467.2/373.1 | 65 | 8 |
(丙酸氯倍他索) | 467.2/355.1* | 8 | |||
23 | fluticasone propionate | 17.79 | 501.2/312.9* | 110 | 24 |
(丙酸氟替卡松) | 501.2/292.9 | 44 | |||
24 | clobetasone butyrate | 18.84 | 479.2/279.1 | 80 | 16 |
(丁酸氯倍他松) | 479.2/71.1* | 16 | |||
cortisol-d4 | 6.15 | 367.2/121.0* | 120 | 27 | |
dexamethasone-d4 | 11.36 | 397.2/377.2* | 75 | 0 | |
triamcinoloneacetonide-13C3 | 12.39 | 438.2/318.2* | 75 | 4 | |
budesonide-d8 | 15.33 | 439.0/421.0* | 110 | 12 | |
fluticasone propionate-d5 | 17.83 | 506.2/312.9* | 110 | 24 |
表 1 24种目标化合物的质谱参数
Table 1 Mass spectrometric parameters for the 24 target compounds
No. | Compound | Retention time/min | Monitoring ion pair (m/z) | Fragmentor/V | Collision energy/eV |
---|---|---|---|---|---|
1 | triamcinolone | 2.61 | 395.2/375.1* | 140 | 4 |
(曲安西龙) | 395.2/225.1 | 12 | |||
2 | aldosterone | 4.51 | 361.0/315.0 | 70 | 8 |
(醛固酮) | 361.0/343.0* | 4 | |||
3 | prednisolone | 5.73 | 361.2/343.2* | 70 | 4 |
(泼尼松龙) | 361.2/147.1 | 24 | |||
4 | cortisol | 6.11 | 363.2/327.2 | 95 | 12 |
(皮质醇) | 363.2/121.0* | 120 | 27 | ||
5 | prednisone | 6.19 | 359.2/171.0 | 95 | 36 |
(泼尼松) | 359.2/147.0* | 32 | |||
6 | cortisone | 6.76 | 361.2/163.1* | 150 | 12 |
(可的松) | 361.2/121.0 | 4 | |||
7 | methylprednisolone | 10.23 | 375.2/357.1* | 110 | 6 |
(甲基泼尼松龙) | 375.2/161.1 | 20 | |||
8 | betamethasone | 11.13 | 393.2/373.2* | 75 | 0 |
(倍他米松) | 393.2/355.2 | 8 | |||
9 | dexamethasone | 11.25 | 393.2/373.2* | 75 | 0 |
(地塞米松) | 393.2/355.2 | 8 | |||
10 | flumethasone | 11.59 | 411.2/253.1* | 70 | 12 |
(氟米松) | 411.2/121.0 | 40 | |||
11 | corticosterone | 11.63 | 347.0/121.0* | 20 | 25 |
(皮质酮) | 347.0/329.0 | 25 | |||
12 | beclomethasone | 11.86 | 409.2/391.1* | 110 | 6 |
(倍氯米松) | 409.2/146.9 | 30 | |||
13 | flunisolide | 12.40 | 495.2/121.0* | 90 | 16 |
(氟尼缩松) | 495.2/319.1 | 44 | |||
14 | triamcinolone acetonide | 12.52 | 435.2/415.2* | 75 | 4 |
(曲安奈德) | 435.2/397.2 | 12 | |||
15 | fluocinolone acetonide | 13.34 | 453.2/413.3* | 90 | 8 |
(醋酸氟轻松) | 453.2/337.2 | 8 | |||
16 | fluorometholone | 13.71 | 377.2/121.0* | 80 | 36 |
(氟米龙) | 377.2/173.1 | 24 | |||
17 | fludrocortisone acetate | 13.84 | 423.2/238.9* | 150 | 22 |
(醋酸氟氢可的松) | 432.2/120.9 | 36 | |||
18 | deflazacort | 14.04 | 442.2/123.9* | 170 | 50 |
(地夫可特) | 442.2/141.9 | 36 | |||
19 | budesonide | 15.43 | 431.2/147.0* | 90 | 36 |
(布地奈德) | 431.1/173.1 | 28 | |||
20 | deoxycorticosterone acetate | 17.20 | 373.24/97.1* | 110 | 28 |
(醋酸脱氧皮质酮) | 373.2/108.9 | 20 | |||
21 | amcinonide | 17.36 | 503.2/339.1* | 75 | 12 |
(安西奈德) | 503.2/399.2 | 8 | |||
22 | clobetasol propionate | 17.61 | 467.2/373.1 | 65 | 8 |
(丙酸氯倍他索) | 467.2/355.1* | 8 | |||
23 | fluticasone propionate | 17.79 | 501.2/312.9* | 110 | 24 |
(丙酸氟替卡松) | 501.2/292.9 | 44 | |||
24 | clobetasone butyrate | 18.84 | 479.2/279.1 | 80 | 16 |
(丁酸氯倍他松) | 479.2/71.1* | 16 | |||
cortisol-d4 | 6.15 | 367.2/121.0* | 120 | 27 | |
dexamethasone-d4 | 11.36 | 397.2/377.2* | 75 | 0 | |
triamcinoloneacetonide-13C3 | 12.39 | 438.2/318.2* | 75 | 4 | |
budesonide-d8 | 15.33 | 439.0/421.0* | 110 | 12 | |
fluticasone propionate-d5 | 17.83 | 506.2/312.9* | 110 | 24 |
图3 氟尼缩松、醋酸氟氢可的松、皮质酮、丙酸氯倍他索和丁酸倍他松经LC-NH2 SPE柱净化前、后的MRM色谱图
Fig. 3 MRM chromatograms of flunisolide, fludrocortisone acetate, corticosterone, clobetasol propionate and clobetasone butyrate before and after purified by LC-NH2 cartridges
图5 24种目标物混合标准溶液(20 μg/L)在(a)正离子模式、(b)负离子模式、和(c)正负离子模式下的总离子色谱图
Fig. 5 Total ion chromatograms (TIC) of the 24 target compounds at mass concentration of 20 μg/L in (a) positive ion mode, (b) negative ion mode, and (c) positive and negative ion mode For peak Nos., see Table 1.
Compound | Linear equation | R2 | LOD/ (μg/kg) | LOQ/ (μg/kg) | MEs/% | |
---|---|---|---|---|---|---|
a | b | |||||
Triamcinolone | y=1.10×103x+6.44×104 | 0.999 | 1.06 | 2 | -7.7 | 5.7 |
Aldosterone | y=3.52×103x-3.41×103 | 0.999 | 0.50 | 2.26 | 20.3 | 16.5 |
Prednisolone | y=1.10×104x-8.32×104 | 0.999 | 1.25 | 1.82 | 32.9 | 11.6 |
Cortisol | y=1.29×103x-7.79×102 | 0.999 | 0.27 | 1.14 | 31.5 | 23.4 |
Prednisone | y=7.64×102x+3.63×102 | 0.998 | 0.33 | 0.91 | 26.2 | 18.8 |
Cortisone | y=6.78×102x-3.82×102 | 0.999 | 0.17 | 0.26 | 16.0 | 10.7 |
Methylprednisolone | y=3.42×103x-1.37×103 | 0.999 | 0.45 | 1.20 | 26.3 | 16.3 |
Betamethasone | y=2.55×104x-1.54×104 | 0.999 | 0.47 | 0.93 | 15.8 | 10.4 |
Dexamethasone | y=2.76×104x-2.14×104 | 0.999 | 0.50 | 1.35 | 21.3 | 14.7 |
Flumethasone | y=1.31×103x+8.83×102 | 0.999 | 0.47 | 1.14 | 10.1 | -4.3 |
Corticosterone | y=2.17×103x-2.05×103 | 0.999 | 0.48 | 1.18 | 22.7 | 14.3 |
Beclomethasone | y=1.31×104x-7.56×102 | 0.998 | 0.57 | 1.45 | 49.9 | 18.2 |
Flunisolide | y=1.45×102x+3.48×103 | 0.999 | 0.57 | 1.55 | 19.3 | -7.9 |
Triamcinolone acetonide | y=3.55×103x+8.79×102 | 0.998 | 0.63 | 1.63 | 34.8 | 21.8 |
Fluocinolone acetonide | y=2.42×103x-1.46×103 | 0.999 | 0.29 | 0.88 | 28.0 | -4.4 |
Fluorometholone | y=5.89×103x-1.61×104 | 0.995 | 0.60 | 1.69 | 21.2 | 11.4 |
Fludrocortisone acetate | y=5.62×102x+6.41×102 | 0.997 | 0.58 | 1.37 | 19.6 | 15.9 |
Deflazacort | y=1.45×104x-1.02×104 | 0.997 | 0.14 | 0.33 | 31.1 | 25.2 |
Budesonide | y=2.16×103x+3.61×102 | 0.997 | 0.51 | 1.31 | 71.8 | 24.3 |
Deoxycorticosterone acetate | y=8.20×103x+5.04×102 | 0.999 | 0.42 | 0.98 | 74.5 | 27.5 |
Amcinonide | y=6.01×103x-2.38×103 | 0.998 | 0.57 | 1.16 | 45.5 | -3.4 |
Clobetasol propionate | y=3.55×103x-3.09×103 | 0.998 | 0.42 | 1.64 | 24.7 | -0.9 |
Fluticasone propionate | y=1.12×103x+5.60×102 | 0.995 | 0.47 | 1.44 | 61.3 | 27.9 |
Clobetasone butyrate | y=3.64×103x-3.17×103 | 0.999 | 0.56 | 1.48 | 43.7 | 9.3 |
表 2 24种目标化合物的线性方程、相关系数、检出限、定量限和基质效应
Table 2 Linear equations, correlation coefficients (R2), limits of detection (LODs), limits of quantification (LOQs) and matrix effects (MEs) for the 24 target compounds
Compound | Linear equation | R2 | LOD/ (μg/kg) | LOQ/ (μg/kg) | MEs/% | |
---|---|---|---|---|---|---|
a | b | |||||
Triamcinolone | y=1.10×103x+6.44×104 | 0.999 | 1.06 | 2 | -7.7 | 5.7 |
Aldosterone | y=3.52×103x-3.41×103 | 0.999 | 0.50 | 2.26 | 20.3 | 16.5 |
Prednisolone | y=1.10×104x-8.32×104 | 0.999 | 1.25 | 1.82 | 32.9 | 11.6 |
Cortisol | y=1.29×103x-7.79×102 | 0.999 | 0.27 | 1.14 | 31.5 | 23.4 |
Prednisone | y=7.64×102x+3.63×102 | 0.998 | 0.33 | 0.91 | 26.2 | 18.8 |
Cortisone | y=6.78×102x-3.82×102 | 0.999 | 0.17 | 0.26 | 16.0 | 10.7 |
Methylprednisolone | y=3.42×103x-1.37×103 | 0.999 | 0.45 | 1.20 | 26.3 | 16.3 |
Betamethasone | y=2.55×104x-1.54×104 | 0.999 | 0.47 | 0.93 | 15.8 | 10.4 |
Dexamethasone | y=2.76×104x-2.14×104 | 0.999 | 0.50 | 1.35 | 21.3 | 14.7 |
Flumethasone | y=1.31×103x+8.83×102 | 0.999 | 0.47 | 1.14 | 10.1 | -4.3 |
Corticosterone | y=2.17×103x-2.05×103 | 0.999 | 0.48 | 1.18 | 22.7 | 14.3 |
Beclomethasone | y=1.31×104x-7.56×102 | 0.998 | 0.57 | 1.45 | 49.9 | 18.2 |
Flunisolide | y=1.45×102x+3.48×103 | 0.999 | 0.57 | 1.55 | 19.3 | -7.9 |
Triamcinolone acetonide | y=3.55×103x+8.79×102 | 0.998 | 0.63 | 1.63 | 34.8 | 21.8 |
Fluocinolone acetonide | y=2.42×103x-1.46×103 | 0.999 | 0.29 | 0.88 | 28.0 | -4.4 |
Fluorometholone | y=5.89×103x-1.61×104 | 0.995 | 0.60 | 1.69 | 21.2 | 11.4 |
Fludrocortisone acetate | y=5.62×102x+6.41×102 | 0.997 | 0.58 | 1.37 | 19.6 | 15.9 |
Deflazacort | y=1.45×104x-1.02×104 | 0.997 | 0.14 | 0.33 | 31.1 | 25.2 |
Budesonide | y=2.16×103x+3.61×102 | 0.997 | 0.51 | 1.31 | 71.8 | 24.3 |
Deoxycorticosterone acetate | y=8.20×103x+5.04×102 | 0.999 | 0.42 | 0.98 | 74.5 | 27.5 |
Amcinonide | y=6.01×103x-2.38×103 | 0.998 | 0.57 | 1.16 | 45.5 | -3.4 |
Clobetasol propionate | y=3.55×103x-3.09×103 | 0.998 | 0.42 | 1.64 | 24.7 | -0.9 |
Fluticasone propionate | y=1.12×103x+5.60×102 | 0.995 | 0.47 | 1.44 | 61.3 | 27.9 |
Clobetasone butyrate | y=3.64×103x-3.17×103 | 0.999 | 0.56 | 1.48 | 43.7 | 9.3 |
Compound | 5 μg/kg | 20 μg/kg | 50 μg/kg | |||||
---|---|---|---|---|---|---|---|---|
Recovery/% | RSD/% | Recovery/% | RSD/% | Recovery/% | RSD/% | |||
Triamcinolone | 65.8 | 3.8 | 87.3 | 5.7 | 78.9 | 6.5 | ||
Aldosterone | 87.0 | 1.3 | 76.5 | 3.2 | 86.7 | 8.4 | ||
Prednisolone | 84.2 | 2.6 | 74.4 | 1.9 | 92.8 | 3.5 | ||
Cortisol | 70.5 | 0.7 | 75.5 | 6.0 | 80.0 | 2.2 | ||
Prednisone | 94.3 | 1.8 | 86.6 | 1.3 | 94.5 | 6.1 | ||
Cortisone | 72.1 | 3.5 | 68.0 | 0.4 | 72.6 | 4.0 | ||
Methylprednisolone | 76.8 | 4.3 | 75.7 | 1.9 | 83.8 | 9.7 | ||
Betamethasone | 73.3 | 4.4 | 81.4 | 2.1 | 73.6 | 2.9 | ||
Dexamethasone | 74.0 | 5.4 | 78.0 | 2.7 | 88.3 | 12.6 | ||
Corticosterone | 70.3 | 4.8 | 72.3 | 1.4 | 73.5 | 9.4 | ||
Flumethasone | 77.6 | 3.3 | 89.0 | 0.7 | 92.5 | 5.4 | ||
Beclomethasone | 66.0 | 6.3 | 80.8 | 3.6 | 78.7 | 7.1 | ||
Flunisolide | 74.3 | 5.5 | 83.8 | 2.3 | 80.8 | 3.1 | ||
Triamcinolone acetonide | 72.2 | 3.5 | 76.3 | 7.1 | 85.8 | 3.4 | ||
Fluocinolone acetonide | 74.3 | 9.4 | 83.4 | 6.0 | 75.5 | 1.7 | ||
Fluorometholone | 64.9 | 5.2 | 85.8 | 2.3 | 90.7 | 3.1 | ||
Fludrocortisone acetate | 76.5 | 3.8 | 80.5 | 0.9 | 86.7 | 5.6 | ||
Deflazacort | 71.3 | 2.2 | 75.8 | 3.4 | 125.1 | 8.6 | ||
Budesonide | 70.4 | 3.4 | 75.1 | 7.8 | 71.7 | 9.5 | ||
Deoxycorticosterone acetate | 79.2 | 6.3 | 69.5 | 1.5 | 86.1 | 11.8 | ||
Amcinonide | 78.3 | 4.1 | 81.0 | 7.9 | 79.9 | 6.0 | ||
Clobetasol propionate | 88.1 | 5.8 | 68.2 | 8.1 | 75.2 | 3.2 | ||
Fluticasone propionate | 68.2 | 4.9 | 70.7 | 2.7 | 68.5 | 11.0 | ||
Clobetasone butyrate | 79.2 | 5.4 | 85.9 | 4.4 | 96.7 | 5.1 |
表 3 沉积物中24种皮质类固醇激素的加标回收率及精密度(n=5)
Table 3 Spiked recoveries and precisions of the 24 target compounds in sediment (n=5)
Compound | 5 μg/kg | 20 μg/kg | 50 μg/kg | |||||
---|---|---|---|---|---|---|---|---|
Recovery/% | RSD/% | Recovery/% | RSD/% | Recovery/% | RSD/% | |||
Triamcinolone | 65.8 | 3.8 | 87.3 | 5.7 | 78.9 | 6.5 | ||
Aldosterone | 87.0 | 1.3 | 76.5 | 3.2 | 86.7 | 8.4 | ||
Prednisolone | 84.2 | 2.6 | 74.4 | 1.9 | 92.8 | 3.5 | ||
Cortisol | 70.5 | 0.7 | 75.5 | 6.0 | 80.0 | 2.2 | ||
Prednisone | 94.3 | 1.8 | 86.6 | 1.3 | 94.5 | 6.1 | ||
Cortisone | 72.1 | 3.5 | 68.0 | 0.4 | 72.6 | 4.0 | ||
Methylprednisolone | 76.8 | 4.3 | 75.7 | 1.9 | 83.8 | 9.7 | ||
Betamethasone | 73.3 | 4.4 | 81.4 | 2.1 | 73.6 | 2.9 | ||
Dexamethasone | 74.0 | 5.4 | 78.0 | 2.7 | 88.3 | 12.6 | ||
Corticosterone | 70.3 | 4.8 | 72.3 | 1.4 | 73.5 | 9.4 | ||
Flumethasone | 77.6 | 3.3 | 89.0 | 0.7 | 92.5 | 5.4 | ||
Beclomethasone | 66.0 | 6.3 | 80.8 | 3.6 | 78.7 | 7.1 | ||
Flunisolide | 74.3 | 5.5 | 83.8 | 2.3 | 80.8 | 3.1 | ||
Triamcinolone acetonide | 72.2 | 3.5 | 76.3 | 7.1 | 85.8 | 3.4 | ||
Fluocinolone acetonide | 74.3 | 9.4 | 83.4 | 6.0 | 75.5 | 1.7 | ||
Fluorometholone | 64.9 | 5.2 | 85.8 | 2.3 | 90.7 | 3.1 | ||
Fludrocortisone acetate | 76.5 | 3.8 | 80.5 | 0.9 | 86.7 | 5.6 | ||
Deflazacort | 71.3 | 2.2 | 75.8 | 3.4 | 125.1 | 8.6 | ||
Budesonide | 70.4 | 3.4 | 75.1 | 7.8 | 71.7 | 9.5 | ||
Deoxycorticosterone acetate | 79.2 | 6.3 | 69.5 | 1.5 | 86.1 | 11.8 | ||
Amcinonide | 78.3 | 4.1 | 81.0 | 7.9 | 79.9 | 6.0 | ||
Clobetasol propionate | 88.1 | 5.8 | 68.2 | 8.1 | 75.2 | 3.2 | ||
Fluticasone propionate | 68.2 | 4.9 | 70.7 | 2.7 | 68.5 | 11.0 | ||
Clobetasone butyrate | 79.2 | 5.4 | 85.9 | 4.4 | 96.7 | 5.1 |
Compound | Sample 1 | Sample 2 | Sample 3 |
---|---|---|---|
Triamcinolone | 3.78 | <LOQ | ND |
Aldosterone | ND | ND | ND |
Prednisolone | ND | ND | ND |
Cortisol | ND | ND | ND |
Prednisone | ND | ND | ND |
Cortisone | ND | ND | ND |
Methylprednisolone | ND | ND | ND |
Betamethasone | 4.21 | ND | <LOQ |
Dexamethasone | 9.63 | ND | <LOQ |
Corticosterone | ND | ND | <LOQ |
Flumethasone | ND | ND | ND |
Beclomethasone | ND | ND | ND |
Triamcinolone acetonide | 2.19 | ND | ND |
Fluocinolone acetonide | 2.80 | ND | ND |
Fludrocortisone acetate | ND | ND | ND |
Deflazacort | <LOQ | <LOQ | <LOQ |
Fluorometholone | 4.32 | ND | ND |
Budesonide | ND | ND | ND |
Flunisolide | 8.62 | 29.38 | ND |
Deoxycorticosterone acetate | 7.51 | 22.35 | 1.28 |
Amcinonide | <LOQ | 22.37 | 1.42 |
Clobetasol propionate | 1.25 | 2.71 | ND |
Fluticasone propionate | 2.03 | 1.85 | ND |
Clobetasone butyrate | ND | 6.52 | <LOQ |
表 4 珠江三角洲河流沉积物样品中的皮质类固醇激素含量
Table 4 Contents of corticosteroids in the sediment sample from the rivers of Pearl River Delta μg/kg
Compound | Sample 1 | Sample 2 | Sample 3 |
---|---|---|---|
Triamcinolone | 3.78 | <LOQ | ND |
Aldosterone | ND | ND | ND |
Prednisolone | ND | ND | ND |
Cortisol | ND | ND | ND |
Prednisone | ND | ND | ND |
Cortisone | ND | ND | ND |
Methylprednisolone | ND | ND | ND |
Betamethasone | 4.21 | ND | <LOQ |
Dexamethasone | 9.63 | ND | <LOQ |
Corticosterone | ND | ND | <LOQ |
Flumethasone | ND | ND | ND |
Beclomethasone | ND | ND | ND |
Triamcinolone acetonide | 2.19 | ND | ND |
Fluocinolone acetonide | 2.80 | ND | ND |
Fludrocortisone acetate | ND | ND | ND |
Deflazacort | <LOQ | <LOQ | <LOQ |
Fluorometholone | 4.32 | ND | ND |
Budesonide | ND | ND | ND |
Flunisolide | 8.62 | 29.38 | ND |
Deoxycorticosterone acetate | 7.51 | 22.35 | 1.28 |
Amcinonide | <LOQ | 22.37 | 1.42 |
Clobetasol propionate | 1.25 | 2.71 | ND |
Fluticasone propionate | 2.03 | 1.85 | ND |
Clobetasone butyrate | ND | 6.52 | <LOQ |
|
[1] | 赵芮, 黄晴雯, 余智颖, 韩铮, 范楷, 赵志辉, 聂冬霞. QuEChERS-超高效液相色谱-串联质谱法同时测定水果中36种真菌毒素[J]. 色谱, 2023, 41(9): 760-770. |
[2] | 岳超, 赵超群, 毛思浩, 王展华, 施贝, 徐欣丰, 梁晶晶. 通过式固相萃取净化-超高效液相色谱-串联质谱法测定液体乳中10种氨基甲酸酯类农药残留[J]. 色谱, 2023, 41(9): 807-813. |
[3] | 孟二琼, 念琪循, 李峰, 张秋萍, 许茜, 王春民. 磺酸化磁性氮化碳固相萃取-超高液相色谱-串联质谱筛检淡水鱼中孔雀石绿和隐色孔雀石绿[J]. 色谱, 2023, 41(8): 673-682. |
[4] | 高祎阳, 丁亚丽, 陈鲁玉, 杜芳, 辛绪波, 冯娟娟, 孙明霞, 冯洋, 孙敏. 共价有机框架材料在固相萃取中的最新应用进展[J]. 色谱, 2023, 41(7): 545-553. |
[5] | 秦童童, 高莉, 赵文杰. 超交联多孔有机聚合物在柱固相萃取中的应用进展[J]. 色谱, 2023, 41(7): 554-561. |
[6] | 陈东洋, 张昊, 张磊, 王一红, 王小丹, 冯家力, 梁静, 钟旋. 固相萃取-超高效液相色谱-串联质谱法测定发酵食品中的曲酸[J]. 色谱, 2023, 41(7): 632-639. |
[7] | 王秋旭, 冯启言, 朱雪强. 加速溶剂萃取-固相萃取净化结合超高效液相色谱-串联质谱法测定沉积物中双酚类化合物[J]. 色谱, 2023, 41(7): 582-590. |
[8] | 夏宝林, 汪仕韬, 殷晶晶, 张维益, 杨娜, 刘强, 吴海晶. 自动上样固相萃取-超高效液相色谱-串联质谱法同时测定水中9类43种抗菌药物残留[J]. 色谱, 2023, 41(7): 591-601. |
[9] | 赵原庆, 胡锴, 杨成, 韩鹏昭, 李立新, 刘晓冰, 张振强, 张书胜. 基于Ti3C2Tx/聚酰亚胺复合材料的分散固相萃取-液相色谱法测定尿液中儿茶酚胺类神经递质[J]. 色谱, 2023, 41(7): 572-581. |
[10] | 童学智, 陈东洋, 冯家力, 范翔, 张昊, 杨胜园. QuEChERS-超高效液相色谱-串联质谱法快速测定水产品中5种卤代苯醌[J]. 色谱, 2023, 41(6): 490-496. |
[11] | 王园媛, 李璐璐, 吕佳, 陈永艳, 张岚. 固相萃取-超高效液相色谱-三重四极杆质谱法测定饮用水中13种卤代苯醌类消毒副产物[J]. 色谱, 2023, 41(6): 482-489. |
[12] | 宁晓盼, 姚倩, 许忠祥, 殷耀, 柳菡, 张晓燕, 丁涛, 张勇, 侯玉, 王梦茹, 吴丽娜, 汤奇婷. 固相萃取-高效液相色谱法测定水产调味品中7种对羟基苯甲酸酯类防腐剂[J]. 色谱, 2023, 41(6): 513-519. |
[13] | 董婧妍, 宋素平, 孙秀梅, 金衍健, 郝青, 朱剑, 李铁军. 复合层析柱净化-气相色谱-负化学源质谱法测定海洋沉积物中多溴联苯醚[J]. 色谱, 2023, 41(6): 535-542. |
[14] | 曾永福, 陈美芳, 邵雨, 闫永欢, 张海超, 王敬, 艾连峰, 康维钧. 植物中27种典型药品及个人护理品多残留检测方法的建立及其在芽苗菜中迁移规律的分析[J]. 色谱, 2023, 41(5): 386-396. |
[15] | 李振环, 胡小键, 陆一夫, 谢琳娜, 朱英. 基于高通量全自动固相萃取的超高效液相色谱-串联质谱法测定人尿中16种抗生素和4种β-受体激动剂[J]. 色谱, 2023, 41(5): 397-408. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||